Director Jon R. Moeller filed a Form 4 with the SEC on November 17, 2026, disclosing an acquisition of Eli Lilly common stock on November 16, 2026.
Key Highlights
- Reporting person: Jon R. Moeller, listed as a Director of Eli Lilly & Co (NYSE:LLY).
- Transaction: Acquisition (code A) of 167.6364 shares of common stock on November 16, 2026.
- Price per share: $1,431.67, as reported in the filing.
- Beneficial ownership following transaction: 473.021 shares of common stock held directly.
- Filing date: November 17, 2026, signed by Jonathan Groff for Jon R. Moeller pursuant to authorization on file.
Moeller's November 2026 Common Stock Acquisition at Eli Lilly
According to the filing, Jon R. Moeller, identified as a Director of Eli Lilly & Co (NYSE:LLY), reported an acquisition of 167.6364 shares of Eli Lilly common stock on November 16, 2026. The transaction was recorded with a price of $1,431.67 per share and a transaction code of "A," indicating an acquisition of securities.
Following the reported transaction, the filing states that Moeller directly holds 473.021 shares of Eli Lilly common stock. No derivative securities transactions were reported in Table II of the filing. The form was filed on November 17, 2026, and was signed by Jonathan Groff for Jon R. Moeller pursuant to an authorization on file. No amendment date was listed, indicating this is an original filing.
The filing does not indicate that the transaction was made pursuant to a Rule 10b5-1(c) plan, as the corresponding checkbox on the form was not checked. The reporting person's address is listed as Lilly Corporate Center, Indianapolis, Indiana 46285.
What Was Disclosed
The Form 4 discloses a single acquisition of 167.6364 shares of Eli Lilly & Co common stock by Director Jon R. Moeller on November 16, 2026, at $1,431.67 per share, bringing his direct beneficial ownership to 473.021 shares.




Please wait processing your request...